糖尿病の微小血管合併症：企業と競争環境...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 9
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
3 Market Outlook 13
3.1 Global Markets 13
3.1.1 Forecast 13
3.1.2 Drivers and Barriers – Global Issues 17
4 Current and Future Players 20
4.1 Overview 20
4.2 Trends in Corporate Strategy 22
4.3 Company Profiles 25
4.3.1 Roche 25
4.3.2 Novartis 27
4.3.3 Regeneron 29
4.3.4 Bayer 31
4.3.5 Eli Lilly 32
4.3.6 Pfizer 35
4.3.7 AbbVie 37
5 Appendix 40
5.1 Bibliography 40
5.2 Abbreviations 42
5.3 Methodology 44
5.4 Forecasting Methodology 44
5.4.1 Diagnosed Patients 44
5.4.2 Percent Drug-Treated Patients 45
5.4.3 General Pricing Assumptions 45
5.5 Physicians and Specialists Included in this Study 46
5.6 About the Authors 48
5.6.1 Analyst II – CVMD 48
5.6.2 Therapy Director – CVMD and Infectious Disease 48
5.6.3 Global Head of Healthcare 49
5.7 About GlobalData 50
5.8 Disclaimer 50